Determination of formaldehyde in food and feed by an in-house validated HPLC method von Wahed, P., Razzaq, Md.A., Dharmapuri, S., Corrales, M.

Volltext

Study of chemical composition and nutritional values of vegetable wastes in Bangladesh von Das, N.G., Huque, K.S., Amanullah, S.M., Dharmapuri, S., Makkar, H.P.S.

Volltext

Adenovirus as vehicle for anticancer genetic immunotherapy von Gallo, P, Dharmapuri, S, Cipriani, B, Monaci, P

Volltext

Intratumor RNA interference of cell cycle genes slows down tumor progression von Dharmapuri, S, Peruzzi, D, Marra, E, Palombo, F, Bett, A J, Bartz, S R, Yong, M, Ciliberto, G, La Monica, N, Buser, C A, Toniatti, C, Aurisicchio, L

Volltext

An oral TLR7 agonist is a potent adjuvant of DNA vaccination in transgenic mouse tumor models von Dharmapuri, S, Aurisicchio, L, Neuner, P, Verdirame, M, Ciliberto, G, La Monica, N

Volltext

Novel genomic locus with atypical G+C content that is required for extracellular polysaccharide production and virulence in Xanthomonas oryzae pv. oryzae von DHARMAPURL, Sridhar, YASHITOLA, J, VISHNUPRIYA, M. R, SONTI, Ramesh V

Volltext

759P - Outcomes of hepatocellular carcinoma (HCC) patients treated with nivolumab: The Mount Sinai Hospital experience von Dharmapuri, S., Özbek, U., Lin, J.-Y., Schwartz, M., Branch, A., Ang, C.

Volltext

744PPredictive value of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) In hepatocellular carcinoma (HCC) patients treated with nivolumab (N) von Dharmapuri, S, Özbek, U, Lin, J-Y, Schwartz, M, Branch, A, Ang, C

Volltext

759POutcomes of hepatocellular carcinoma (HCC) patients treated with nivolumab: The Mount Sinai Hospital experience von Dharmapuri, S, Özbek, U, Lin, J-Y, Schwartz, M, Branch, A, Ang, C

Volltext

744P - Predictive value of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) In hepatocellular carcinoma (HCC) patients treated with nivolumab (N) von Dharmapuri, S., Özbek, U., Lin, J.-Y., Schwartz, M., Branch, A., Ang, C.

Volltext

Predictive value of neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) In hepatocellular carcinoma (HCC) patients treated with nivolumab (N) von Dharmapuri, S., Özbek, U., Lin, J.-Y., Schwartz, M., Branch, A., Ang, C.

Volltext

Outcomes of hepatocellular carcinoma (HCC) patients treated with nivolumab: The Mount Sinai Hospital experience von Dharmapuri, S., Özbek, U., Lin, J.-Y., Schwartz, M., Branch, A., Ang, C.

Volltext

Metabolic engineering of beta‐carotene and lycopene content in tomato fruit von Rosati, Carlo, Aquilani, Riccardo, Dharmapuri, Sridhar, Pallara, Patrizia, Marusic, Carla, Tavazza, Raffaela, Bouvier, Florence, Camara, Bilal, Giuliano, Giovanni

Volltext

Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma von Jun, T, Ozbek, U, Dharmapuri, S, Hardy-Abeloos, C, Zhu, H, Lin, J-Y, Personeni, N, Pressiani, T, Lee, P, Lee, C, Hildebrand, H, Nimkar, N, Paul, S, Fessas, P, Naeem, M, Bettinger, D, Khan, U, Saeed, A, Huang, Y, Kudo, M, Rimassa, L, Marron, T, Pinato, D, Ang, C

Volltext

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade von Pinato, DJ, Kaneko, T, Saeed, A, Pressiani, T, Kaseb, A, Wang, Y, Szafron, D, Jun, T, Dharmapuri, S, Naqash, AR, Muzaffar, M, Navaid, M, Lee, C-J, Bulumulle, A, Yu, B, Paul, S, Nimkar, N, Bettinger, D, Hildebrand, H, Abugabal, YI, Ang, C, Marron, TU, Khan, U, Personeni, N, Rimassa, L, Huang, Y-H

Volltext

Metabolic engineering of xanthophyll content in tomato fruits von Dharmapuri, Sridhar, Rosati, Carlo, Pallara, Patrizia, Aquilani, Riccardo, Bouvier, Florence, Camara, Bilal, Giuliano, Giovanni

Volltext

Antiapoptotic Small Interfering RNA as Potent Adjuvant of DNA Vaccination in a Mouse Mammary Tumor Model von DHARMAPURI, Sridhar, AURISICCHIO, Luigi, BIONDO, Antonella, WELSH, Natalie, CILIBERTO, Gennaro, LA MONICA, Nicola

Volltext

Analysis of a Stitched Double Cantilever Beam von Sankar, Bhavani V., Dharmapuri, Sreerama M.

Volltext

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC von Sharma, R, Pillai, A, Marron, TU, Fessas, P, Saeed, A, Jun, T, Dharmapuri, S, Szafron, D, Naqash, AR, Gampa, A, Wang, Y, Khan, U, Muzaffar, M, Lee, C-J, Lee, P-C, Bulumulle, A, Paul, S, Bettinger, D, Hildebrand, H, Yehia, M, Pressiani, T, Kaseb, A, Huang, Y-H, Ang, C, Kudo, M, Nishida, N, Personeni, N, Rimassa, L, Pinato, DJ

Volltext

Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapy von Pinato, DJ, Kaseb, A, Wang, Y, Saeed, A, Szafron, D, Jun, T, Dharmapuri, S, Naqash, AR, Muzaffar, M, Navaid, M, Khan, U, Lee, C, Bulumulle, A, Yu, B, Paul, S, Fessas, P, Nimkar, N, Bettinger, D, Hildebrand, H, Pressiani, T, Abugabal, Y, Personeni, N, Huang, Y-H, Lozano-Kuehne, J, Rimassa, L, Ang, C, Marron, TU

Volltext